This topic contains a solution. Click here to go to the answer

Author Question: Which of the following may cause cross-sensitivity in the patient who is receiving epoetin alfa ... (Read 67 times)

Haya94

  • Hero Member
  • *****
  • Posts: 558
Which of the following may cause cross-sensitivity in the patient who is receiving epoetin alfa (Epogen)?
 
  a. Albumin
  b. Lactose
  c. Nitrates
  d. Synthetic insulin

Question 2

The patient has been placed on deferoxamine (Deseral) therapy. Which adverse effect of the drug must the health care provider monitor closely for, to prevent death of the patient?
 
  a. Red discoloration of the urine
  b. Proliferation of specific organisms leading to infection
  c. Ocular toxicity
  d. Auditory neurotoxicity



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mjenn52

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

ANS: A
Epoetin alfa is contraindicated for use in patients with hypersensitivity to albumin or mammalian cell-derived products, or in those with uncontrolled hypertension.

Answer to Question 2

ANS: B
Because deferoxamine is a naturally occurring iron siderophore (a molecule facilitating iron up-take), it acts as a growth factor for Yersinia and Rhizopus. In susceptible individuals, deferox-amine increases the proliferation and virulence of these organisms, resulting in severe, often fatal, infection.




Haya94

  • Member
  • Posts: 558
Reply 2 on: Jul 23, 2018
Gracias!


triiciiaa

  • Member
  • Posts: 349
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

For a complete list of videos, visit our video library